1. Home
  2. ANEB vs PMN Comparison

ANEB vs PMN Comparison

Compare ANEB & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANEB
  • PMN
  • Stock Information
  • Founded
  • ANEB 2020
  • PMN 2004
  • Country
  • ANEB United States
  • PMN Canada
  • Employees
  • ANEB N/A
  • PMN N/A
  • Industry
  • ANEB Biotechnology: Pharmaceutical Preparations
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • ANEB Health Care
  • PMN Health Care
  • Exchange
  • ANEB Nasdaq
  • PMN Nasdaq
  • Market Cap
  • ANEB 36.7M
  • PMN 29.8M
  • IPO Year
  • ANEB 2021
  • PMN N/A
  • Fundamental
  • Price
  • ANEB $1.54
  • PMN $0.97
  • Analyst Decision
  • ANEB Buy
  • PMN
  • Analyst Count
  • ANEB 1
  • PMN 0
  • Target Price
  • ANEB $8.00
  • PMN N/A
  • AVG Volume (30 Days)
  • ANEB 13.3K
  • PMN 40.8K
  • Earning Date
  • ANEB 02-11-2025
  • PMN 03-31-2025
  • Dividend Yield
  • ANEB N/A
  • PMN N/A
  • EPS Growth
  • ANEB N/A
  • PMN N/A
  • EPS
  • ANEB N/A
  • PMN N/A
  • Revenue
  • ANEB N/A
  • PMN N/A
  • Revenue This Year
  • ANEB N/A
  • PMN N/A
  • Revenue Next Year
  • ANEB N/A
  • PMN N/A
  • P/E Ratio
  • ANEB N/A
  • PMN N/A
  • Revenue Growth
  • ANEB N/A
  • PMN N/A
  • 52 Week Low
  • ANEB $0.80
  • PMN $0.87
  • 52 Week High
  • ANEB $3.30
  • PMN $2.61
  • Technical
  • Relative Strength Index (RSI)
  • ANEB 48.92
  • PMN 56.16
  • Support Level
  • ANEB $1.45
  • PMN $0.90
  • Resistance Level
  • ANEB $1.75
  • PMN $0.95
  • Average True Range (ATR)
  • ANEB 0.14
  • PMN 0.06
  • MACD
  • ANEB -0.01
  • PMN 0.01
  • Stochastic Oscillator
  • ANEB 41.78
  • PMN 67.79

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: